Approved by the FDA in March 1996, Fexofenadine is a puzzling small molecule drug that works as an H1 receptor antagonist.

23andMe Commences Early-Stage Clinical Evaluation of Its Bifunctional Antibody, 23ME-01473, Aimed at ULBP6.

Pharmacovigilance is the science and practice of monitoring the safety and adverse effects of medications that are prescribed, sold, or otherwise in use.

Nurix Unveils the Innovation and Molecular Configuration of Pioneering CBL-B Suppressant NX-1607 during the ACS Conference.

Fluticasone Propionate, a small molecule drug, targets the glucocorticoid receptor and acts as an agonist.

Bristol Myers Squibb Reveals Successful Outcome for CheckMate -9DW Study Assessing the Combination of Opdivo and Yervoy in Extending Survival in Initial Therapy of Progressive Liver Cancer.

Over-the-counter (OTC) drugs are medications that can be purchased and used without a prescription from a healthcare provider.

The FDA has approved Idorsia's daily drug TRYVIO (aprocitentan), the first to use an endothelin receptor antagonist for managing resistant hypertension alongside other medications.

Propofol, an agonist of the GABAA receptor, is a small molecule drug primarily used for anesthesia.

Mabwell's novel antibody-drug conjugate targeting Nectin-4 in cervical cancer shows significant treatment promise according to initial clinical findings.

An orphan drug is a pharmaceutical product that is developed to treat, diagnose, or prevent rare diseases or conditions.

Dr. Reddy’s Laboratories Ltd., an international enterprise specializing in pharmaceuticals, has officially declared the introduction of its drug Versavo® (bevacizumab) to the UK market.